GenuIN Biotech

GenuIN Biotech is an innovative biotechnology company based in India, specializing in induced pluripotent stem cell (iPSC) technology and advanced genome engineering. Incubated at the Indian Institute of Science (IISc), the company provides a robust platform for generating human iPSCs and differentiating them into specialized cell types such as neurons and cardiomyocytes. These high-fidelity human cell models are utilized for disease modeling, drug discovery, and toxicity screening, offering a more accurate alternative to traditional animal models. GenuIN Biotech also leverages CRISPR/Cas9 technology to create custom gene-edited cell lines, enabling researchers to study specific genetic mutations and their roles in various pathologies. Their services are designed to streamline the drug development process and facilitate the transition toward personalized medicine. By bridging the gap between laboratory research and clinical applications, GenuIN Biotech aims to accelerate the development of novel therapeutics for complex diseases.